Bartlett, Nathan W.

Role of deficient type III interferon-λ production in asthma exacerbations

Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A. B., Bartlett, N. W., Kebadze, T., Mallia, P., Stanciu, L. A., Parker, H. L., et al. (2006) · Nature Medicine

interferon and immune responsesAsthma and respiratory diseases

Cited by 1,006

Targeting the NF-κB pathway in asthma and chronic obstructive pulmonary disease

Edwards, M. R., Bartlett, N. W., Clarke, D., Birrell, M., Belvisi, M., & Johnston, S. L. (2009) · Pharmacology & Therapeutics

NF-κB Signaling PathwaysAsthma and respiratory diseases

Cited by 375

Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation

Bartlett, N. W., Walton, R. P., Edwards, M. R., Aniscenko, J., Caramori, G., Zhu, J., Glanville, N., Choy, K. J., Jourdan, P., Burnet, J., et al. (2008) · Nature Medicine

Respiratory viral infections researchAsthma and respiratory diseases

Cited by 375

Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation

Beale, J., Jayaraman, A., Jackson, D. J., Macintyre, J. D. R., Edwards, M. R., Walton, R. P., Zhu, J., Ching, Y. M., Shamji, B., Edwards, M., et al. (2014) · Science Translational Medicine

Asthma and respiratory diseasesIL-33, ST2, and ILC Pathways

Cited by 332

The microbiology of asthma

Edwards, M. R., Bartlett, N. W., Hussell, T., Openshaw, P., & Johnston, S. L. (2012) · Nature Reviews Microbiology

Asthma and respiratory diseasesOccupational exposure and asthma

Cited by 205